Other
Revenue
Edwards Lifesciences Revenue increased by 5.0% to $1.65B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.7%, from $1.41B to $1.65B. Over 4 years (FY 2021 to FY 2025), Revenue shows an upward trend with a 3.8% CAGR.
Analysis
StatementCash Flow Statement
SectionOther
First reportedQ1 2016
Last reportedQ1 2026May 6, 2026
Metric ID:
other_revenue_from_contract_with_customer_excluding_asse_0d5b70Historical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.38B | $1.31B | $1.33B | $1.34B | $1.37B | $1.32B | $429.9M | $1.22B | $1.28B | $1.24B | $1.27B | $1.33B | $1.37B | $1.35B | $1.39B | $1.41B | $1.53B | $1.55B | $1.57B | $1.65B |
| QoQ Change | — | -4.8% | +1.5% | +0.9% | +2.4% | -4.0% | -67.4% | +184.1% | +4.7% | -2.8% | +1.8% | +5.0% | +3.0% | -1.1% | +2.3% | +1.9% | +8.5% | +1.4% | +1.1% | +5.0% |
| YoY Change | — | — | — | — | -0.2% | +0.7% | -67.7% | -8.9% | -6.9% | -5.7% | +194.6% | +8.9% | +7.1% | +8.9% | +9.4% | +6.2% | +11.9% | +14.7% | +13.3% | +16.7% |
Range$429.9M – $1.65B
CAGR+3.9%
Avg YoY Growth+12.7%
Median YoY Growth+8.0%
Current Streak6 quarters growth
Revenue at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's revenue?
- Edwards Lifesciences (EW) reported revenue of $1.65B in Q1 2026.
- How has Edwards Lifesciences's revenue changed year-over-year?
- Edwards Lifesciences's revenue increased by 16.7% year-over-year, from $1.41B to $1.65B.
- What is the long-term trend for Edwards Lifesciences's revenue?
- Over 4 years (2021 to 2025), Edwards Lifesciences's revenue has grown at a 3.8% compound annual growth rate (CAGR), from $5.23B to $6.07B.